$AMRI Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ALBANY MOLECULAR RESEARCH INC. Get notifications about new insider transactions in ALBANY MOLECULAR RESEARCH INC for free.

Page: < prev 1 2 3 4 5 6 7 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 20 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Buy	M	2.93	1,250	3,663	34,683	33.4 K to 34.7 K (+3.74 %)
May 16 2014	AMRI	ALBANY MOLECULAR R ...	Svokos George	SVP Sales & GM of A ...	Buy	P	15.60	10,000	156,000	54,584	44.6 K to 54.6 K (+22.43 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Marth William S	President and CEO	Buy	P	15.40	30,000	462,000	313,699	283.7 K to 313.7 K (+10.57 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Option Exercise	M	2.93	2,500	7,325	20,000
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Option Exercise	M	2.93	2,500	7,325	22,500
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Sell	S	15.27	2,500	38,175	33,433	35.9 K to 33.4 K (-6.96 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Buy	M	2.93	2,500	7,325	35,933	33.4 K to 35.9 K (+7.48 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Sell	S	14.80	2,500	37,000	33,433	35.9 K to 33.4 K (-6.96 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Buy	M	2.93	2,500	7,325	35,933	33.4 K to 35.9 K (+7.48 %)
May 13 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	SVP Pharmaceutical ...	Sell	S	14.80	897	13,276	33,433	34.3 K to 33.4 K (-2.61 %)
May 05 2014	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	15.98	30,000	479,400	4,263,289	4.3 M to 4.3 M (-0.70 %)
May 01 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Sell	S	15.73	2,500	39,325	53,997	56.5 K to 54 K (-4.43 %)
Apr 02 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Sell	S	18.74	2,500	46,850	56,497	59 K to 56.5 K (-4.24 %)
Apr 02 2014	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	18.52	30,000	555,600	4,293,289	4.3 M to 4.3 M (-0.69 %)
Mar 18 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	254	0	34,330	34.6 K to 34.3 K (-0.73 %)
Mar 12 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	254	0	34,584	34.8 K to 34.6 K (-0.73 %)
Mar 05 2014	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	15.42	30,000	462,600	4,323,289	4.4 M to 4.3 M (-0.69 %)
Feb 28 2014	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	M	12.85	5,000	64,250	0
Feb 28 2014	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Sell	S	15.95	5,000	79,750	36,856	41.9 K to 36.9 K (-11.95 %)
Feb 28 2014	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Buy	M	12.85	5,000	64,250	41,856	36.9 K to 41.9 K (+13.57 %)
Feb 28 2014	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	M	12.85	5,000	64,250	0
Feb 28 2014	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Buy	M	12.85	5,000	64,250	40,210	35.2 K to 40.2 K (+14.20 %)
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Option Exercise	M	2.93	2,500	7,325	25,000
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	15.19	2,500	37,975	34,838	37.3 K to 34.8 K (-6.70 %)
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Buy	M	2.93	2,500	7,325	37,338	34.8 K to 37.3 K (+7.18 %)
Feb 27 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Option Exercise	M	9.34	3,000	28,020	0
Feb 27 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	15.73	3,000	47,190	34,838	37.8 K to 34.8 K (-7.93 %)
Feb 27 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Buy	M	9.34	3,000	28,020	37,838	34.8 K to 37.8 K (+8.61 %)
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Option Exercise	M	3.43	15,000	51,450	85,000
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Sell	S	15.00	15,000	225,000	76,093	91.1 K to 76.1 K (-16.47 %)
Feb 25 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Buy	M	3.43	15,000	51,450	91,093	76.1 K to 91.1 K (+19.71 %)
Feb 24 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	14.87	1,500	22,305	34,838	36.3 K to 34.8 K (-4.13 %)
Feb 19 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Payment of Exercise	F	0.00	1,038	0	58,997	60 K to 59 K (-1.73 %)
Feb 19 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	13.37	1,500	20,055	36,338	37.8 K to 36.3 K (-3.96 %)
Feb 19 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	1,038	0	37,838	38.9 K to 37.8 K (-2.67 %)
Feb 14 2014	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.00	30,000	360,000	4,353,289	4.4 M to 4.4 M (-0.68 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Svokos George	Sr. VP Sales & GM o ...	Option Exercise	A	10.43	29,167	304,212	29,167
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Svokos George	Sr. VP Sales & GM o ...	Grant	A	10.43	14,584	152,111	44,584	30 K to 44.6 K (+48.61 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Luther Michael A	Senior VP, Discover ...	Option Exercise	A	10.43	25,000	260,750	25,000
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Luther Michael A	Senior VP, Discover ...	Grant	A	10.43	12,500	130,375	32,500	20 K to 32.5 K (+62.50 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Option Exercise	A	10.43	29,167	304,212	29,167
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Grant	A	10.43	14,584	152,111	60,035	45.5 K to 60 K (+32.09 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Payment of Exercise	F	0.00	948	0	45,451	46.4 K to 45.5 K (-2.04 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Option Exercise	A	10.43	25,000	260,750	25,000
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Grant	A	10.43	12,500	130,375	38,876	26.4 K to 38.9 K (+47.39 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Option Exercise	A	10.43	33,333	347,663	33,333
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Grant	A	10.43	16,666	173,826	76,093	59.4 K to 76.1 K (+28.04 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Marth William S	President and CEO	Grant	A	10.50	95,238	999,999	283,699	188.5 K to 283.7 K (+50.53 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	10.43	3,356	35,003	30,874	27.5 K to 30.9 K (+12.20 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	10.43	3,356	35,003	36,856	33.5 K to 36.9 K (+10.02 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	10.43	3,356	35,003	35,210	31.9 K to 35.2 K (+10.54 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Grant	A	10.43	3,356	35,003	28,677	25.3 K to 28.7 K (+13.25 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	10.43	3,356	35,003	33,937	30.6 K to 33.9 K (+10.97 %)
Feb 04 2014	AMRI	ALBANY MOLECULAR R ...	Marth William S	President and CEO	Payment of Exercise	F	0.00	1,905	0	188,461	190.4 K to 188.5 K (-1.00 %)
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, Board of ...	Option Exercise	A	10.43	7,201	75,106	7,201
Feb 06 2014	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, Board of ...	Grant	A	10.43	3,356	35,003	2,848,546	2.8 M to 2.8 M (+0.12 %)
Feb 04 2014	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Payment of Exercise	F	0.00	1,384	0	59,427	60.8 K to 59.4 K (-2.28 %)
Feb 04 2014	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, Secretary & Gen ...	Payment of Exercise	F	0.00	1,106	0	46,399	47.5 K to 46.4 K (-2.33 %)
Feb 04 2014	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	1,038	0	26,376	27.4 K to 26.4 K (-3.79 %)
Jan 03 2014	AMRI	ALBANY MOLECULAR R ...	Marth William S	President and CEO	Grant	A	10.08	99,207	1,000,007	190,366	91.2 K to 190.4 K (+108.83 %)
Jan 03 2014	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, Board of ...	Grant	A	10.08	99,207	1,000,007	2,845,190	2.7 M to 2.8 M (+3.61 %)
Dec 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Option Exercise	M	2.93	2,500	7,325	27,500
Dec 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	10.93	2,500	27,325	27,414	29.9 K to 27.4 K (-8.36 %)
Dec 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Buy	M	2.93	2,500	7,325	29,914	27.4 K to 29.9 K (+9.12 %)
Dec 04 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.00	1,900	22,800	4,383,289	4.4 M to 4.4 M (-0.04 %)
Dec 04 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Buy	P	10.75	30,000	322,500	91,159	61.2 K to 91.2 K (+49.05 %)
Nov 22 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	11.55	2,300	26,565	27,414	29.7 K to 27.4 K (-7.74 %)
Nov 22 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Buy	P	11.57	20,000	231,400	61,159	41.2 K to 61.2 K (+48.59 %)
Nov 06 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	362	0	29,714	30.1 K to 29.7 K (-1.20 %)
Nov 05 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	13.06	30,000	391,800	4,385,189	4.4 M to 4.4 M (-0.68 %)
Oct 03 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.85	30,000	385,500	4,415,189	4.4 M to 4.4 M (-0.67 %)
Sep 18 2013	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Payment of Exercise	F	0.00	4,522	0	60,811	65.3 K to 60.8 K (-6.92 %)
Sep 17 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.00	30,000	360,000	4,445,189	4.5 M to 4.4 M (-0.67 %)
Aug 02 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.53	30,000	375,900	4,475,189	4.5 M to 4.5 M (-0.67 %)
Jul 02 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.47	30,000	374,100	4,505,189	4.5 M to 4.5 M (-0.66 %)
Jun 13 2013	AMRI	ALBANY MOLECULAR R ...	CABLE STUART M	10% Owner	Sell	S	12.00	30,000	360,000	4,535,189	4.6 M to 4.5 M (-0.66 %)
Jun 06 2013	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	10.46	1,434	15,000	27,518	26.1 K to 27.5 K (+5.50 %)
Jun 06 2013	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	10.46	396	4,142	33,500	33.1 K to 33.5 K (+1.20 %)
Jun 06 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Grant	A	10.46	2,868	29,999	41,159	38.3 K to 41.2 K (+7.49 %)
Jun 06 2013	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	10.46	1,434	15,000	31,854	30.4 K to 31.9 K (+4.71 %)
Jun 06 2013	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	10.46	1,434	15,000	30,581	29.1 K to 30.6 K (+4.92 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Payment of Exercise	F	0.00	454	0	55,386	55.8 K to 55.4 K (-0.81 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	D	0.00	1,250	0	55,840	57.1 K to 55.8 K (-2.19 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Payment of Exercise	F	0.00	477	0	47,505	48 K to 47.5 K (-0.99 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Sell	D	0.00	1,458	0	47,982	49.4 K to 48 K (-2.95 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Payment of Exercise	F	0.00	454	0	30,076	30.5 K to 30.1 K (-1.49 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	D	0.00	1,250	0	30,530	31.8 K to 30.5 K (-3.93 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Sell	D	0.00	6,667	0	2,745,983	2.8 M to 2.7 M (-0.24 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	7,000	0	2,752,650	2.8 M to 2.8 M (-0.25 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	7,000	0	2,679,318	2.7 M to 2.7 M (-0.26 %)
Jun 04 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Buy	P	10.23	10,000	102,300	38,291	28.3 K to 38.3 K (+35.35 %)
May 31 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	11.26	800	9,008	31,780	32.6 K to 31.8 K (-2.46 %)
May 23 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Option Exercise	M	2.93	7,500	21,975	22,500
May 23 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	10.97	7,500	82,275	57,090	64.6 K to 57.1 K (-11.61 %)
May 23 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Buy	M	2.93	7,500	21,975	64,590	57.1 K to 64.6 K (+13.14 %)
May 13 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	10.40	1,200	12,480	32,580	33.8 K to 32.6 K (-3.55 %)
Apr 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	10,200	0	2,686,318	2.7 M to 2.7 M (-0.38 %)
Apr 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	10,200	0	2,759,650	2.8 M to 2.8 M (-0.37 %)
Mar 20 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	9.91	258	2,557	57,090	57.3 K to 57.1 K (-0.45 %)
Mar 20 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	9.98	256	2,555	57,348	57.6 K to 57.3 K (-0.44 %)
Mar 20 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	9.91	180	1,784	33,780	34 K to 33.8 K (-0.53 %)
Mar 20 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	9.98	249	2,485	33,960	34.2 K to 34 K (-0.73 %)
Mar 14 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	10.75	677	7,278	34,209	34.9 K to 34.2 K (-1.94 %)
Mar 13 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	10.69	852	9,108	57,604	58.5 K to 57.6 K (-1.46 %)
Mar 13 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	10.75	694	7,461	58,456	59.2 K to 58.5 K (-1.17 %)
Mar 13 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	10.73	1,070	11,481	59,150	60.2 K to 59.2 K (-1.78 %)
Mar 13 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	10.25	3,538	36,265	60,220	63.8 K to 60.2 K (-5.55 %)
Mar 11 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	9.56	1,000	9,560	34,886	35.9 K to 34.9 K (-2.79 %)
Feb 26 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	8.18	984	8,049	35,886	36.9 K to 35.9 K (-2.67 %)
Feb 26 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	8.18	984	8,049	63,758	64.7 K to 63.8 K (-1.52 %)
Feb 21 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	7.89	1,000	7,890	36,870	37.9 K to 36.9 K (-2.64 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Option Exercise	A	5.99	80,000	479,200	80,000
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Grant	A	5.99	26,666	159,729	2,769,850	2.7 M to 2.8 M (+0.97 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Option Exercise	A	5.99	35,000	209,650	35,000
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Grant	A	5.99	11,666	69,879	49,440	37.8 K to 49.4 K (+30.88 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Option Exercise	A	5.99	30,000	179,700	30,000
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Grant	A	5.99	10,000	59,900	37,870	27.9 K to 37.9 K (+35.88 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Option Exercise	A	5.99	40,000	239,600	40,000
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Nolan Michael M	VP, CFO and Treasur ...	Grant	A	5.99	13,333	79,865	63,333	50 K to 63.3 K (+26.67 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Option Exercise	A	5.99	30,000	179,700	30,000
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Grant	A	5.99	10,000	59,900	64,742	54.7 K to 64.7 K (+18.27 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	5.99	5,843	35,000	26,084	20.2 K to 26.1 K (+28.87 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	5.99	5,843	35,000	33,104	27.3 K to 33.1 K (+21.43 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	5.99	5,843	35,000	30,420	24.6 K to 30.4 K (+23.77 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Grant	A	5.99	5,843	35,000	28,291	22.4 K to 28.3 K (+26.03 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Grant	A	5.99	5,843	35,000	25,321	19.5 K to 25.3 K (+30.00 %)
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	5.99	12,367	74,078	12,367
Feb 04 2013	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	5.99	5,843	35,000	29,147	23.3 K to 29.1 K (+25.07 %)
Jan 02 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	375,000	0	2,696,518	3.1 M to 2.7 M (-12.21 %)
Jan 02 2013	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	375,000	0	2,743,184	3.1 M to 2.7 M (-12.03 %)
Dec 04 2012	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Buy	P	5.00	10,000	50,000	22,448	12.4 K to 22.4 K (+80.33 %)
Nov 19 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Buy	P	3.80	10,000	38,000	3,118,184	3.1 M to 3.1 M (+0.32 %)
Nov 19 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Buy	P	3.80	10,000	38,000	3,071,518	3.1 M to 3.1 M (+0.33 %)
Nov 06 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	Sr VP Pharmaceutica ...	Sell	S	3.51	372	1,306	27,870	28.2 K to 27.9 K (-1.32 %)
Sep 14 2012	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Sell	D	0.00	11,666	0	62,933	74.6 K to 62.9 K (-15.64 %)
Sep 07 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	1,500,000	0	3,125,434	4.6 M to 3.1 M (-32.43 %)
Sep 07 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	1,500,000	0	3,078,768	4.6 M to 3.1 M (-32.76 %)
Aug 27 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	3.22	1,000	3,220	28,242	29.2 K to 28.2 K (-3.42 %)
Aug 13 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	25,800	0	4,625,434	4.7 M to 4.6 M (-0.55 %)
Aug 13 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	25,800	0	4,578,768	4.6 M to 4.6 M (-0.56 %)

Page: < prev 1 2 3 4 5 6 7 7 next >